ArticleCancer cell2016

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.

Shom Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.